Potentially life-threatening allergic reaction, Anaphylaxis onsets rapidly and may cause severe swelling, breathing problems, loss of blood pressure, and death. Indicated for the treatment of allergic reactions, Adrenaclick
Targeting Her2-positive breast cancer, ARX788 is developed by the clinical stage biopharmaceutical company Ambrx as site-specific ADC. According to the deal, both the companies will continue developing the
The JV will focus on developing novel modulators of the alpha7 nicotinic acetylcholine receptor that is believed to play a vital role in cognition. CoMentis president and CEO
Reducing the risk of death by 52% in a three-year follow-up analysis of the COMFORT-II study, Jakavi was well tolerated and impacted an underlying mechanism of disease and
Garcinia Cambogia Extract consists of Hydroxycitric Acid (HCA), which enables weight loss more than three times than diet and exercise alone, according to a study published by Dr.
Plans about the project was announced by the company in 2010 and also received $8.4m in loans from the local government and other assistance from the city. City
The collaboration will integrate Genmab’s high-affinity fully human antibody targeting CD25, HuMax-TAC, with ADC’s PBD-based warhead and linker technology for the devlopment of new product. Genmab chief executive
The company will unveil the platform at the 49th Drug Information Association (DIA) annual meeting scheduled to be held between 23 June 2013 and 27 June 2013 in
An orally available Janus kinase (JAK) inhibitor, Baricitinib is being studied to treat certain autoimmune conditions, including RA. Clinical improvements which were observed at 24-week continued at the
The study is intended to assess safety, tolerability and efficacy in patients suffering from one of the most serious manifestations of systemic lupus erythematosus (SLE or lupus) that
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.